about
Novel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approachProtein kinase C, an elusive therapeutic target?Rottlerin exhibits anti-cancer effect through inactivation of S phase kinase-associated protein 2 in pancreatic cancer cells.Tamoxifen use for the management of mania: a review of current preclinical evidence.Polyphenol compounds and PKC signaling.Protein kinase C and cardiac dysfunction: a review.Rottlerin as a therapeutic approach in psoriasis: Evidence from in vitro and in vivo studies.
P2860
Q28535430-AC1411D6-2A50-42A3-8EEA-70313D906FDBQ37141320-B9B0AFF0-9B5A-44DA-9CB1-14486C5878A2Q37382511-CCFC0911-C4BF-459E-9D09-2053550D11CCQ38179926-D58C3E7E-C26A-40EC-99BB-411577253EBDQ38846159-86ED8723-6B47-404B-ACF7-05C3FBC0F173Q39432092-7C2CD12B-C976-4AB6-91F1-A315349504A8Q48355290-5C809C27-B71A-497F-BF85-2F7120FA3BF1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rottlerin: bases for a possible usage in psoriasis.
@en
Rottlerin: bases for a possible usage in psoriasis.
@nl
type
label
Rottlerin: bases for a possible usage in psoriasis.
@en
Rottlerin: bases for a possible usage in psoriasis.
@nl
prefLabel
Rottlerin: bases for a possible usage in psoriasis.
@en
Rottlerin: bases for a possible usage in psoriasis.
@nl
P1476
Rottlerin: bases for a possible usage in psoriasis
@en
P2093
Giuseppe Valacchi
P304
P356
10.2174/138920010791526097
P407
P577
2010-06-01T00:00:00Z